Topics › Drug Policy
Commentary by Geoffrey Lawrence and Madison Carlino
Psychedelics Policy Newsletter by Gregory Ferenstein
Commentary by Geoffrey Lawrence and Khurshid Khoja
Commentary by Gregory Ferenstein
Policy Brief by Michelle Minton
Policy Brief by Geoffrey Lawrence and Michelle Minton
Commentary by Gregory Ferenstein and Geoffrey Lawrence
Commentary by Geoffrey Lawrence